Atrium Therapeutics

Business Services · California, United States · 501-1,000 Employees

View Company Info for Free

Overview

Headquarters

10578 Science Center Dr Ste 125, San Die...

Phone Number

(619) 876-0700

Revenue

$35.8 Million

Industry

Business Services Research & Development

About Atrium Therapeutics

Atrium Therapeutics is a biopharmaceutical company pioneering targeted RNA therapeutics for cardiomyopathies. Its proprietary, non-viral delivery platform combines tissue-selective targeting with the precision of oligonucleotides, enabling selective delivery of siRNA to cardiac tissues and addressing genetic drivers of disease while aiming to overcome limitations of viral and nanoparticle-based approaches.Explore more
Atrium Therapeutics's Social MediaSIC Code 87,873NAICS Code 54,541Show more

Atrium Therapeutics Org Chart

PhoneEmail
Husam Younis, Chief Scientific Officer at Atrium Therapeutics
United States flag for contact location.

Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
Illustration of an envelope

Top Business Services Companies

Frequently Asked Questions Regarding Atrium Therapeutics

What is Atrium Therapeutics's official website?
Atrium Therapeutics's official website is www.atriumtherapeutics.com
What is Atrium Therapeutics's Revenue?
Atrium Therapeutics's revenue is $35.8 Million
What is Atrium Therapeutics's SIC code?
Atrium Therapeutics's SIC: 87,873
What is Atrium Therapeutics's NAICS code?
Atrium Therapeutics's NAICS: 54,541
How many employees does Atrium Therapeutics have?
Atrium Therapeutics has 501-1,000 employees
What industry does Atrium Therapeutics belong to?
Atrium Therapeutics is in the industry of: Business Services, Research & Development
How do I contact Atrium Therapeutics?
Atrium Therapeutics contact info: Phone number: (619) 876-0700 Website: www.atriumtherapeutics.com
What does Atrium Therapeutics do?

Atrium Therapeutics is a biopharmaceutical company pioneering targeted RNA therapeutics for cardiomyopathies. Its proprietary, non-viral delivery platform combines tissue-selective targeting with the precision of oligonucleotides, enabling selective delivery of siRNA to cardiac tissues and addressing genetic drivers of disease while aiming to overc... ome limitations of viral and nanoparticle-based approaches.Read More

What are Atrium Therapeutics social media links?
Atrium Therapeutics Linkedin page
Who invested in Atrium Therapeutics?
Atrium Therapeutics has 5 investors including Sessa Capital Im, Sessa Capital Im, Casdin Capital and Aberdeen.
Is Atrium Therapeutics a public company?
Atrium Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Atrium Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.